We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Endoscopic Therapy Opens Strictures in IBD Children

By HospiMedica International staff writers
Posted on 27 May 2014
A new study reports that endoscopic balloon therapy can successfully dilate strictures in the gastrointestinal (GI) tract in children caused by consequences of inflammatory bowel disease (IBD), thus avoiding or delaying surgery.

Researchers at the University of California, San Francisco (UCSF; Fresno, USA) conducted a prospective pilot study to evaluate the use of endoscopic balloon dilation plus intramural corticosteroid injection in 12 patients (median age 14.5 years), 8 of whom were boys. More...
The 12 patients had 13 strictures: One in the esophagus, one in the antrum, four in the right colon and seven in the ileum. Overall, the 12 patients were treated with 15 dilatation procedures.

The results showed that nine of the children required just a single procedure; two children needed a second endoscopic procedure, and one child eventually required surgery to maintain the opening of the strictures. Of the 12 children, 11 (92%) have not required further treatment. The children that underwent a re-dilatation when their symptoms returned and imaging showed that the strictures had narrowed. The procedure has already been performed on another 15 children, but they have not yet reached the one-year milestone. The study was presented at Digestive Disease Week (DDW), held during May 2014 in Chicago (IL, USA).

“We have not had any endoscopic-related complications; we have had no perforations. There is always some bleeding when you dilate any stricture—it is something you want to see because it indicates you are dilating the stricture. But we have had no major bleeding incidents,” said lead author and study presenter assistant professor of pediatric gastroenterology Roberto Gugig, MD. “If we can prevent surgery for a year or 3 years or 5 years, then maybe we are having an impact on the natural history of the disease. We might be able to change the statistics. That's my goal.”

The endoscopic balloon technique, which takes about 20–40 minutes, is similar to angioplasty in the arteries, but uses a larger balloon which is filled with water and a contrast agent to assess how well the dilatation is proceeding. According to the researchers, the procedure appears to work better when there is active inflammation when the endoscopy is performed.

Related Links:

University of California, San Francisco (Fresno) 



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.